Report of the International League Against Epilepsy Commission on Economic Aspects of Epilepsy

Epilepsia

Volumn 37, Issue 5, 1996, Pages 506-508

  Beran, R G ^a   Pachlatko, C ^a  

^a SWISS EPILEPSY CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; EPILEPSY; HEALTH CARE COST; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029936789     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00600.x     Document Type: Article

References (6)

1. Begley Ch, Annegers J, Lairson D, Reynolds T, Hauser W. Cost of Epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 1994 ; 35: 1230–43.
2. Beran R, Pachlatko Ch, eds. Cost of epilepsy: proceedings of the 20th International Epilepsy Congress in Oslo 1993. Wehr: Ciba‐Geigy Verlag, 1995.
3. Cockerell O, Hart Y, Sander J, Shorvon S. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population‐based studies. Epilepsy Res 1994 ; 18: 249–60.
4. Gessner U, Sagmeister M, Horisberger B. The cost of epilepsy in Switzerland. Int J Health Sci 1993 ; 4: 121–8.
5. Luce B, Elixhauser A. Standards for socieoeconomic evaluation of health care, products and services. Berlin: Springer‐Verlag, 1990.
6. Silfvenius H. Economic costs of epilepsy—treatment benefits. Acta Neurol Scand 1988 ; suppl 117: 698–705.